[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

City of Fort Wayne proposing changes to food, alcohol requirements for Riverfront Liquor Licenses

Cash Jordan: Migrant MOB BLOCKS Whitehouse… Demands ‘11 Million Illegals’ Stay

Not much going on that I can find today

In Britain, they are secretly preparing for mass deaths

These Are The Best And Worst Countries For Work (US Last Place)-Life Balance

These Are The World's Most Powerful Cars

Doctor: Trump has 6 to 8 Months TO LIVE?!

Whatever Happened to Robert E. Lee's 7 Children

Is the Wailing Wall Actually a Roman Fort?

Israelis Persecute Americans

Israelis SHOCKED The World Hates Them

Ghost Dancers and Democracy: Tucker Carlson

Amalek (Enemies of Israel) 100,000 Views on Bitchute

ICE agents pull screaming illegal immigrant influencer from car after resisting arrest

Aaron Lewis on Being Blacklisted & Why Record Labels Promote Terrible Music

Connecticut Democratic Party Holds Presser To Cry About Libs of TikTok

Trump wants concealed carry in DC.

Chinese 108m Steel Bridge Collapses in 3s, 16 Workers Fall 130m into Yellow River

COVID-19 mRNA-Induced TURBO CANCERS.

Think Tank Urges Dems To Drop These 45 Terms That Turn Off Normies

Man attempts to carjack a New Yorker

Test post re: IRS

How Managers Are Using AI To Hire And Fire People

Israel's Biggest US Donor Now Owns CBS

14 Million Illegals Entered US in 2023: The Cost to Our Nation

American Taxpayers to Cover $3.5 Billion Pentagon Bill for U.S. Munitions Used Defending Israel

The Great Jonny Quest Documentary

This story About IRS Abuse Did Not Post

CDC Data Exposes Surge in Deaths Among Children of Covid-Vaxxed Mothers

This Interview in Munich in 1992 with Gudrun Himmler. (Heinrich Himmler's daughter)


Science/Tech
See other Science/Tech Articles

Title: Japanese team starts world's 1st iPS clinical trial
Source: [None]
URL Source: [None]
Published: Aug 1, 2013
Author: staff
Post Date: 2013-08-01 19:49:31 by Tatarewicz
Ping List: *The Freedom4um Cook Book*     Subscribe to *The Freedom4um Cook Book*
Keywords: None
Views: 24

KOBE, Japan, Aug. 1 (Xinhua) -- Researchers based in the western Japanese city of Kobe started on Thursday a pilot study that uses human induced pluripotent stem (iPS) cells to regenerate human retinas, the world's first clinical trial of iPS cells.

The pilot clinical program is being conducted by a group led by Masayo Takahashi at the Laboratory for Retinal Regeneration, RIKEN Center for Development Biology Kobe Institute in collaboration with the Institute for Biomedical Research and Innovation in Kobe. The city's general hospital will also support the team.

According to RIKEN Kobe, the team plans to transplant autologous iPS cell-derived retinal pigment epithelium (RPE) cell sheets in patients with exudative age-related macular degeneration to check the safety and feasibility of the technique, which is expected to become a new therapy to restore vision.

Takahashi's laboratory said the 6-year and 10-month protocol for the new study will start with the establishment of autologous iPSCs from each of the test subjects. These iPSCs will then be differentiated into RPE cell sheets using a technology that allows these epithelial cells to be transplanted in monolayer cell sheets. The team estimates 10 months for production and validation of the autologous iPSCs and subsequent RPE cell sheets.

RIKEN Kobe Institute spokesperson Naoki Namba said the team has carried out a series of related studies on the possible formation of tumors using animals such as rats and mice. Their ultimate goal is to verify the safety of the RPE cell sheets that may be applied to the human body.

Namba said the team will transplant the tissue into 6 patients selected as early as next summer, who will thereafter be monitored to complete the project over the following years. Editor: Yang Yi Subscribe to *The Freedom4um Cook Book*

Post Comment   Private Reply   Ignore Thread  



[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]